NCT06728319 (CLARIFY) is a clinical trial in Lung Nodules, sponsored by Biodesix, Inc..

Who is sponsoring NCT06728319?

NCT06728319 is sponsored by Biodesix, Inc..

What condition does NCT06728319 study?

NCT06728319 studies Lung Nodules.

Is NCT06728319 still recruiting?

NCT06728319 is currently active, enrolled. Last updated 7 February 2025.

Last reviewed 2025-02-07 · How we verify

NCT06728319: CLARIFY

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World

Active, enrolled Last updated 7 February 2025

What this trial tests

trial in Lung Nodules in 4,000 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

19 September 2024

Primary endpoint
31 July 2026

31 July 2027

Quick facts

Lead sponsor	Biodesix, Inc.
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	4,000
Start date	19 September 2024
Primary completion	31 July 2026
Estimated completion	31 July 2027
Sites	5 locations across United States

Conditions studied

Lung Nodules — all drugs for Lung Nodules →

Sponsor

Biodesix, Inc.

Who can join

40 and older, any sex, with Lung Nodules. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a multicenter retrospective chart review. Sites with at least 100 patients tested with the IC and AAT tests, who have index dates (date of IC and AAT testing) at least one year prior to data collection date will be eligible for participation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Validation of a blood-based autoantibody test to assess lung cancer risk in 4-30 mm pulmonary nodules: a retrospective pooled analysis of four cohort studies.
Pitcher TJ, Long KJ, Kammer MN, Schuldheisz S, et al · · 2026 · PMID 41703731 · DOI 10.1080/14796694.2026.2626339

Verify or expand the search:

Other recruiting trials for Lung Nodules

Currently open trials in the same condition.

NCT07368829 — AI-Driven Autonomous Registration in Robotic Bronchoscopy · NA · recruiting
NCT07057648 — Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea · recruiting
NCT06821451 — Bronchoscopic Navigation Robot-guided Dye Marking-assisted Thoracoscopic Pulmonary Nodule Resection · NA · recruiting
NCT07136961 — Efficacy and Safety of Robotic-assisted Bronchoscopy Combined With the ICNVA Strategy in Biopsy of Peripheral Pulmonary · NA · active not recruiting
NCT07401797 — Specimens for Lung Cancer Panel Design · recruiting

Other Biodesix, Inc. trials

Trials by the same sponsor.

NCT03766958 — A Registry to Evaluate the Performance of the BDX-XL2 Test · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06728319 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Biodesix, Inc.
Last refreshed: 7 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06728319.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing